Global Veterinary Intelligence
Reader login
Veterinary33

Free reader access

Every article remains open. Registration is for participation, not access.

Create a profile to comment, join discussions, receive more relevant recommendations, keep your activity connected, and access selected opportunities.

Debate · Clinical Study · 2 min read

Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs

New university findings highlight potential implications for dogs, cancer, and veterinary practice.

July 29, 2026 at 12:00 PM UTCVeterinary33Veterinary33 Editorial Desk

Comments on this article are also part of the Veterinary33 clinical forum.

Share this article

Share the exact article page with colleagues or your professional network.

LinkedInEmail
Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs

Supported in part by a National Institutes of Health One Health grant, the study also aims to advance translational research between human and veterinary medicine, given the lack of effective treatments for both.

Acute pancreatitis is a painful, life-threatening condition that affects an estimated 1.8 million dogs and accounts for more than 330,000 hospital admissions in humans each year in the United States.

A new clinical trial is now enrolling canine patients, offering hope for improving treatment.

Lamassu Pets, the veterinary division of Lamassu Biotech , and The Ohio State University College of Veterinary Medicine Blue Buffalo Veterinary Clinical Trials Office ( BBVCTO ) have begun testing a canine-specific application of RABI-767, a novel therapeutic targeting acute pancreatitis, a life-threatening condition that currently has no effective treatments in either human or veterinary medicine.

The drug is also being studied in human clinical trials.

The trial, which is supported by the National Institutes of Health (NIH), involves a single injection of the drug delivered directly around the pancreas.

The therapy aims to mitigate symptoms, reduce complications and protect against organ failure.

“For dog owners, this trial provides an opportunity to contribute to insights that could lead to breakthroughs benefiting both pets and people,” said Adam Rudinsky, DVM, associate professor in Ohio State’s Department of Veterinary Clinical Sciences.

“This clinical trial targeting acute pancreatitis in dogs is crucial for advancing veterinary care and improving human health through translational medicine.” The trial aims to provide insights into potential treatment and dosing strategies for dogs with acute pancreatitis.

Canine acute pancreatitis is often a painful, life-threatening diagnosis that can leave them hospitalized for days, or worse,” said Gabi Hanna, MD, CEO of Lamassu Biotech.

“The veterinarians at Ohio State are highly respected in their field, and this clinical trial has the potential to make a significant impact on the field of veterinary medicine.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Ohio State University College of Veterinary Medicine

https://vet.osu.edu/news/ohio-state-launches-clinical-trial-promising-new-treatment-acute-pancreatitis-dogs

Discussion thread

Community replies

1 reply

Editorial connection
Reviewed
Reader avatar: French bulldog puppy
Dr. Elena Marlowe
Veterinary33 Editorial CuratorSmall Animal and Feline MedicineEditorially reviewed

The report highlights the launch of a clinical trial at The Ohio State University to evaluate a novel therapeutic for managing acute pancreatitis in dogs. This investigation into acute abdominal conditions in dogs provides a specific context that is further explored in the Manual of Small Animal Surgical Emergencies by Filippo Cinti, Matteo Rossanese, and Marie Burneko.

Continue exploring

Manual of Small Animal Surgical Emergencies

By Filippo Cinti, Matteo Rossanese, and Marie Burneko

acute abdominal conditions in dogsacutedogssupported

Explore the book for additional coverage of the related themes discussed in this article.

View the book
Open full thread

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

1 reply below

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Log in to reply

Continue the conversation

Share this article with another veterinary professional.

LinkedInEmail
Articles remain free

Create a profile when you are ready to participate.

Veterinary33 does not require registration to read its articles. A free reader profile connects your discussions, recommendations, professional details, and reader activity.

After registration or login, you will return to this exact article.

Registered readers may also receive selected educational and community opportunities.

Join discussions

Comment on articles and participate in professional conversations.

Relevant recommendations

Use your reading and engagement activity to surface more useful articles.

Connected reader activity

Return to your likes, comments, discussions, and article activity in one place.

Professional profile

Add your profession, specialty, workplace, biography, and profile image.

Registration is optional

Continue reading